查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945227

2026年全球胃癌诊断市场报告

Gastric Cancer Diagnostic Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，胃癌诊断市场成长显着，预计到2025年将达到27.8亿美元，到2026年将达到29.8亿美元，复合年增长率为7.2%。过去几年的成长可归因于多种因素，例如萤光探针供应有限、依赖传统的单色FISH技术、基因研究的不断深入、医院和检查室基础设施的改善以及基础细胞遗传学诊断方法的普及。

预计未来几年胃癌诊断市场将维持强劲成长，2030年市场规模将达到38.7亿美元，复合年增长率（CAGR）为6.8%。预测期内的成长要素包括多重和高通量探针的开发、精准医疗需求的成长、基因和药物研究的拓展、影像和定量技术的进步，以及监管合规性和品质标准的加强。预测期内的主要趋势包括多重和高通量FISH探针的日益普及、基因和分子诊断应用的扩展、在临床和药物研究中的日益广泛应用、与先进成像和分析技术的融合，以及对探针准确性和灵敏度的日益重视。

胃癌发生率的上升预计将推动胃癌诊断市场的成长。胃癌是胃黏膜的恶性肿瘤，其特征是细胞不受控制地增殖，并可侵袭或转移至周围组织。病例增加的主要原因是不健康的饮食习惯，例如过量食用盐渍、熏制和加工食品，这些食品会损害胃黏膜并增加癌症风险。胃癌诊断技术能够早期发现恶性病变，有助于儘早实施适当的治疗并改善患者预后。提供快速且准确的结果可提高临床效率并支持更好的疾病管理。例如，根据美国癌症协会2024年5月发布的报告，美国新增胃癌病例数预计将增加至26,890例（高于2023年的26,500例），显示对有效诊断解决方案的需求日益增长。

该市场中的企业正致力于利用人工智慧驱动的内视镜诊断工具进行创新，以实现更早的检测和更高的准确率。以人工智慧为基础的内视镜诊断辅助设备可在内视镜检查过程中即时分析影片影像，以侦测消化器官系统异常情况，包括早期癌症。 2024年3月，日本医疗技术公司AI Medical Services Co., Ltd.发布了「GastroAI-model G」。该系统利用深度学习技术，在内视镜萤幕上突出显示可疑病变，即时提醒医生并提示进行进一步检查或切片检查。这项创新技术提高了诊断准确率，并实现了早期干预，这对改善患者预后至关重要。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球胃癌诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 多重高通量FISH探针的应用日益广泛
    • 不断扩展的基因和分子诊断应用
    • 在临床和药物研究中的应用日益广泛
    • 与先进成像和分析技术的集成
    • 更加重视探头的精度和灵敏度

第五章 终端用户产业市场分析

  • 医院和诊所
  • 研究所
  • 製药公司
  • 生技公司
  • 学术和遗传研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球胃癌诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球胃癌诊断市场规模、比较及成长率分析
  • 全球胃癌诊断市场表现：规模与成长，2020-2025年
  • 全球胃癌诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过诊断方法
  • 内视镜检查、影像诊断、切片检查、临床检测、生物标记检测
  • 副产品
  • 试剂、耗材和设备
  • 透过技术
  • 分子诊断、免疫检测、次世代定序和其他技术
  • 透过使用
  • 早期诊断、筛检和监测
  • 最终用户
  • 医院、诊所、诊断检查室和其他最终用户
  • 按类型细分：内视镜
  • 传统内视镜、染色内视镜、窄频成像、共聚焦雷射内视镜显微镜、胶囊内视镜
  • 按类型细分：诊断成像
  • 电脑断层扫描、磁振造影、正子断层扫描和超音波
  • 按类型细分：切片检查
  • 钳取切片检查、针取切片、超音波引导下切片检查、腹腔镜切片检查
  • 按类型细分：检查
  • 血液检查、粪便检验、尿素呼吸检测、血清学检查
  • 按类型细分：基于生物标誌物的检测
  • 基因检测、蛋白质生物标记检测、循环肿瘤DNA检测、微型RNA检测

第十章 区域与国家分析

  • 全球胃癌诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球胃癌诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 胃癌诊断市场：竞争格局及市场占有率（2024年）
  • 胃癌诊断市场：公司估值矩阵
  • 胃癌诊断市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Quest Diagnostics Incorporated

第37章：其他领先和创新企业

  • Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen NV, DiaSorin SpA, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年胃癌诊断市场：提供新机会的国家
  • 2030年胃癌诊断市场：新兴细分市场机会
  • 2030年胃癌诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MGCDA03_G26Q1

Gastric cancer diagnostics encompass a range of tests and procedures designed to detect and confirm the presence of cancer in the stomach. Their primary objective is to identify gastric tumors at an early stage, determine tumor type and progression, and support effective treatment planning.

The primary types of gastric cancer diagnostics include endoscopy, imaging, biopsy, laboratory tests, and biomarker-based testing. Endoscopy involves inserting a flexible tube equipped with a camera and light to visually examine internal organs and tissues. The products used in these diagnostics include reagents, consumables, and instruments, while the technologies employed range from molecular diagnostics and immunoassays to next-generation sequencing and others. These diagnostics are applied for early detection, screening, and disease monitoring, catering to a wide range of end users such as hospitals, clinics, diagnostic laboratories, and other healthcare facilities.

Tariffs have influenced the FISH probe market by raising the cost of imported fluorescent dyes, probe reagents, and advanced manufacturing equipment. Segments such as multiplex and high-throughput probes are particularly affected, with Asia-Pacific regions including China and India experiencing significant import duties. This has led to higher production costs and potential delays in supply. Positively, tariffs are encouraging local manufacturing, innovation in probe synthesis, and investment in domestic production capabilities, enhancing long-term market resilience.

The gastric cancer diagnostic market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic market statistics, including gastric cancer diagnostic industry global market size, regional shares, competitors with a gastric cancer diagnostic market share, detailed gastric cancer diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic industry. This gastric cancer diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric cancer diagnostic market size has grown strongly in recent years. It will grow from $2.78 billion in 2025 to $2.98 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to limited availability of fluorescent probes, reliance on traditional single-color FISH methods, growing genetic research initiatives, increasing hospital and laboratory infrastructure, adoption of basic cytogenetic diagnostics.

The gastric cancer diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to development of multiplex and high-throughput probes, rising demand for precision medicine, expansion of genetic and pharmaceutical research, technological advancements in imaging and quantification, increasing regulatory compliance and quality standards. Major trends in the forecast period include rising adoption of multiplex and high-throughput fish probes, expansion of genetic and molecular diagnostic applications, growing use in clinical and pharmaceutical research, integration with advanced imaging and analysis technologies, increased focus on probe accuracy and sensitivity.

The rising incidence of gastric cancer is expected to drive growth in the gastric cancer diagnostic market. Gastric cancer, a malignant tumor of the stomach lining, develops when cells grow uncontrollably and can invade surrounding tissues or metastasize. The increase in cases is largely attributed to unhealthy dietary habits, including high consumption of salted, smoked, and processed foods, which damage the stomach lining and elevate cancer risk. Gastric cancer diagnostics facilitate early detection of malignant lesions, enabling timely treatment and improved patient outcomes. They enhance clinical efficiency by providing rapid and accurate results that support better disease management. For example, in May 2024, the American Cancer Society reported 26,890 new stomach cancer cases in the U.S., up from 26,500 in 2023, highlighting the growing need for effective diagnostic solutions.

Companies in this market are innovating with AI-powered endoscopic diagnostic tools to improve early detection and accuracy. AI-based endoscopic diagnostic support devices analyze video images in real time during endoscopy to detect gastrointestinal abnormalities, including early-stage cancer. In March 2024, AI Medical Service Inc., a Japan-based medical technology company, launched GastroAI-model G, which uses deep learning to highlight suspicious lesions on the endoscopic screen, alerting physicians instantly for further examination or biopsy. This innovation improves diagnostic accuracy and enables earlier intervention, which is critical for better patient outcomes.

In April 2025, SSI Diagnostica Group, a Denmark-based microbiology company, acquired Gulf Coast Scientific Corporation, a U.S.-based diagnostics firm specializing in H. pylori testing for gastric cancer risk detection. This acquisition strengthens SSI Diagnostica's gastrointestinal disease testing capabilities, enhances its presence in the U.S. diagnostics market, and supports growth through innovation and complementary technology in gastric cancer diagnostics.

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastric cancer diagnostic market consists of revenues earned by entities by providing services such as genetic counselling, risk assessment programmes, telepathology consultations, and patient navigation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric cancer diagnostics market also includes sales of liquid biopsy kits, rapid diagnostic test (RDT) devices, digital pathology scanners, contrast agents for imaging, and lab-on-a-chip systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gastric cancer diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Type: Endoscopy; Imaging; Biopsy; Laboratory Tests; Biomarker-Based Testing
  • 2) By Product: Reagents And Consumables; Instruments
  • 3) By Technology: Molecular Diagnostics; Immunoassays; Next-Generation Sequencing; Other Technologies
  • 4) By Application: Early Diagnosis; Screening; Monitoring
  • 5) By End User: Hospitals; Clinics; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Endoscopy: Conventional Endoscopy; Chromoendoscopy; Narrow Band Imaging; Confocal Laser Endomicroscopy; Capsule Endoscopy
  • 2) By Imaging: Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography; Ultrasound
  • 3) By Biopsy: Forceps Biopsy; Needle Biopsy; Endoscopic Ultrasound-Guided Biopsy; Laparoscopic Biopsy
  • 4) By Laboratory Tests: Blood Tests; Stool Tests; Urea Breath Test; Serology
  • 5) By Biomarker-Based Testing: Genetic Testing; Protein Biomarker Testing; Circulating Tumor DNA Testing; Microribonucleic Acid Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; Qiagen N.V.; DiaSorin S.p.A; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Foundation Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Fujirebio Inc.; MiRXES Pte Ltd.; BIOCEPT Inc.; Pillar Biosciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Gastric Cancer Diagnostic Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Gastric Cancer Diagnostic Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Gastric Cancer Diagnostic Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Gastric Cancer Diagnostic Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex And High-Throughput Fish Probes
    • 4.2.2 Expansion Of Genetic And Molecular Diagnostic Applications
    • 4.2.3 Growing Use In Clinical And Pharmaceutical Research
    • 4.2.4 Integration With Advanced Imaging And Analysis Technologies
    • 4.2.5 Increased Focus On Probe Accuracy And Sensitivity

5. Gastric Cancer Diagnostic Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Research Laboratories
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Academic And Genetic Research Institutions

6. Gastric Cancer Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastric Cancer Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Gastric Cancer Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Gastric Cancer Diagnostic Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Gastric Cancer Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Gastric Cancer Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastric Cancer Diagnostic Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastric Cancer Diagnostic Market Segmentation

  • 9.1. Global Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing
  • 9.2. Global Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Consumables, Instruments
  • 9.3. Global Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies
  • 9.4. Global Gastric Cancer Diagnostic Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Early Diagnosis, Screening, Monitoring
  • 9.5. Global Gastric Cancer Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Laboratories, Other End Users
  • 9.6. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy
  • 9.7. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound
  • 9.8. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy
  • 9.9. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Tests, Stool Tests, Urea Breath Test, Serology
  • 9.10. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biomarker-Based Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

10. Gastric Cancer Diagnostic Market Regional And Country Analysis

  • 10.1. Global Gastric Cancer Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Gastric Cancer Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastric Cancer Diagnostic Market

  • 11.1. Asia-Pacific Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastric Cancer Diagnostic Market

  • 12.1. China Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastric Cancer Diagnostic Market

  • 13.1. India Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastric Cancer Diagnostic Market

  • 14.1. Japan Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastric Cancer Diagnostic Market

  • 15.1. Australia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastric Cancer Diagnostic Market

  • 16.1. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastric Cancer Diagnostic Market

  • 17.1. South Korea Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastric Cancer Diagnostic Market

  • 18.1. Taiwan Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastric Cancer Diagnostic Market

  • 19.1. South East Asia Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastric Cancer Diagnostic Market

  • 20.1. Western Europe Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastric Cancer Diagnostic Market

  • 21.1. UK Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastric Cancer Diagnostic Market

  • 22.1. Germany Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastric Cancer Diagnostic Market

  • 23.1. France Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastric Cancer Diagnostic Market

  • 24.1. Italy Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastric Cancer Diagnostic Market

  • 25.1. Spain Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastric Cancer Diagnostic Market

  • 26.1. Eastern Europe Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastric Cancer Diagnostic Market

  • 27.1. Russia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastric Cancer Diagnostic Market

  • 28.1. North America Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastric Cancer Diagnostic Market

  • 29.1. USA Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastric Cancer Diagnostic Market

  • 30.1. Canada Gastric Cancer Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastric Cancer Diagnostic Market

  • 31.1. South America Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastric Cancer Diagnostic Market

  • 32.1. Brazil Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastric Cancer Diagnostic Market

  • 33.1. Middle East Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastric Cancer Diagnostic Market

  • 34.1. Africa Gastric Cancer Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastric Cancer Diagnostic Market Regulatory and Investment Landscape

36. Gastric Cancer Diagnostic Market Competitive Landscape And Company Profiles

  • 36.1. Gastric Cancer Diagnostic Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Gastric Cancer Diagnostic Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Gastric Cancer Diagnostic Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Gastric Cancer Diagnostic Market Other Major And Innovative Companies

  • Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

38. Global Gastric Cancer Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Market

40. Gastric Cancer Diagnostic Market High Potential Countries, Segments and Strategies

  • 40.1 Gastric Cancer Diagnostic Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Gastric Cancer Diagnostic Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Gastric Cancer Diagnostic Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer